By Amoako Kwame
The National Health Insurance Authority (NHIA) has suspended three pharmacies from the National Health Insurance Scheme (NHIS) over suspected fraudulent claims and irregularities in service transactions.
In a public notice issued on Thursday, May 14, 2026, the NHIA said the affected facilities had been placed under immediate temporary suspension following a routine claims verification exercise.
The pharmacies are DELDEM PHARMA LIMITED, PARAMEDICA PHARMACY and DESH CHEMIST.
According to the Authority, investigations uncovered “material irregularities in claims and service transactions associated with these facilities”.
It said the findings had “raised reasonable suspicion of fraud and abuse under the NHIS Provider Service Agreement”.
The suspension took effect on May 14, 2026.
During the period of suspension, the pharmacies are barred from providing services or dispensing medicines under the NHIS until further notice.
“The pharmacies are not permitted to provide services or dispense medicines under the NHIS during the suspension,” the statement said.
The NHIA has advised NHIS members who require pharmaceutical services to seek care from other accredited providers across the country.
“NHIS members who require pharmaceutical services are encouraged to seek care from other credentialed NHIS providers nationwide,” the Authority stated.
The NHIA also warned all accredited healthcare providers that it will not tolerate practices that threaten the sustainability of the Scheme.
“The Authority will not tolerate fraudulent or abusive practices that undermine the sustainability of the NHIS, which may deprive members of quality healthcare services,” the statement said.
The Authority further reminded service providers of the legal consequences of defrauding the Scheme.
“A healthcare provider providing services under the National Health Insurance Scheme who defrauds or attempts to defraud the Scheme commits an offence and is liable on summary conviction to a fine or a term of imprisonment of not more than 10 years, or both,” the notice stated.
The statement, signed by the Chief Executive of the NHIA, Dr Victor Asare Bampoe, reaffirmed the Authority’s commitment to transparency, accountability and the prudent use of public funds.
“The NHIA remains committed to ensuring transparency, accountability and the prudent use of public funds in delivering accessible and quality healthcare to all residents of Ghana,” the statement added.
